These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23253841)
1. Current use of calcium channel blockers (CCBs) is associated with an increased risk of gingival hyperplasia. Sanz M J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):147-8. PubMed ID: 23253841 [TBL] [Abstract][Full Text] [Related]
2. Association between calcium channel blockers and gingival hyperplasia. Kaur G; Verhamme KM; Dieleman JP; Vanrolleghem A; van Soest EM; Stricker BH; Sturkenboom MC J Clin Periodontol; 2010 Jul; 37(7):625-30. PubMed ID: 20642630 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users. de Jong HJ; Vandebriel RJ; Saldi SR; van Dijk L; van Loveren H; Cohen Tervaert JW; Klungel OH Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):835-43. PubMed ID: 22674737 [TBL] [Abstract][Full Text] [Related]
5. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836 [TBL] [Abstract][Full Text] [Related]
6. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study. Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826 [TBL] [Abstract][Full Text] [Related]
7. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534 [TBL] [Abstract][Full Text] [Related]
8. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. Rejnmark L; Vestergaard P; Mosekilde L J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study. Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614 [TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Bradbury BD; Lash TL; Kaye JA; Jick SS Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362 [TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers and myocardial infarction: a case--control study in a Japanese hospital. Ohyama Y; Funao K; Kawabe E; Hayashi D; Yamazaki T; Iga T; Koide D; Ohe K; Kubota K Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):487-92. PubMed ID: 12426933 [TBL] [Abstract][Full Text] [Related]
12. Management of periodontal disease in patients using calcium channel blockers - gingival overgrowth, prescribed medications, treatment responses and added treatment costs. Fardal Ø; Lygre H J Clin Periodontol; 2015 Jul; 42(7):640-6. PubMed ID: 26076712 [TBL] [Abstract][Full Text] [Related]
13. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. Opie LH; Yusuf S; Kübler W Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332 [TBL] [Abstract][Full Text] [Related]
14. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. Maxwell CJ; Hogan DB; Ebly EM CMAJ; 1999 Sep; 161(5):501-6. PubMed ID: 10497605 [TBL] [Abstract][Full Text] [Related]
15. Tricyclic antidepressants and the risk of reflux esophagitis. van Soest EM; Dieleman JP; Siersema PD; Schoof L; Sturkenboom MC; Kuipers EJ Am J Gastroenterol; 2007 Sep; 102(9):1870-7. PubMed ID: 17511756 [TBL] [Abstract][Full Text] [Related]
16. Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects. Angeli F; Verdecchia P; Reboldi GP; Gattobigio R; Bentivoglio M; Staessen JA; Porcellati C Am J Hypertens; 2004 Sep; 17(9):817-22. PubMed ID: 15363825 [TBL] [Abstract][Full Text] [Related]
17. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis. Bangalore S; Parkar S; Messerli FH Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231 [TBL] [Abstract][Full Text] [Related]
18. Use of antihypertensives and the risk of Parkinson disease. Becker C; Jick SS; Meier CR Neurology; 2008 Apr; 70(16 Pt 2):1438-44. PubMed ID: 18256367 [TBL] [Abstract][Full Text] [Related]
19. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]
20. Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case-control study. Alharbi FF; Souverein PC; de Groot MC; Maitland-van der Zee AH; de Boer A; Klungel OH J Hum Hypertens; 2017 Aug; 31(8):537-544. PubMed ID: 28332511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]